SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Microvast Holdings, Inc. – MVST

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Microvast Holdings, Inc. (“Microvast” or the “Company”) (NASDAQ: MVST).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Microvast and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Microvast Holdings, Inc. – MVST

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Blue Ridge Bankshares, Inc.- BRBS

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Blue Ridge Bankshares, Inc. (“Blue Ridge” or the “Company”) (NYSE: BRBS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Blue Ridge and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Blue Ridge Bankshares, Inc.- BRBS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fisker Inc. – FSR

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Fisker Inc. (“Fisker” or the “Company”) (NYSE: FSR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  The investigation concerns whether Fisker and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fisker Inc. – FSR

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of National Instruments Corporation – NATI

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of National Instruments Corporation (“NATI” or the “Company”) (NASDAQ: NATI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether NATI and certain of its officers and/or directors have engaged in securities fraud… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of National Instruments Corporation – NATI

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dollar General Corporation – DG

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dollar General Corporation (“Dollar General” or the “Company”) (NYSE: DG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Dollar General and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dollar General Corporation – DG

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ChargePoint Holdings, Inc. – CHPT

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of ChargePoint Holdings, Inc. (“ChargePoint” or the “Company”) (NYSC: CHPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether ChargePoint and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ChargePoint Holdings, Inc. – CHPT

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EHang Holdings Ltd. – EH

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of EHang Holdings Ltd. (“EHang” or the “Company”) (NASDAQ: EH).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether EHang and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EHang Holdings Ltd. – EH

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in The Estee Lauder Companies, Inc. – EL

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Estee Lauder Companies, Inc. (“Estee Lauder” or the “Company”) (NYSE: EL).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Estee Lauder and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in The Estee Lauder Companies, Inc. – EL

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Mercury Systems, Inc. – MRCY

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mercury Systems, Inc.   (“Mercury” or the “Company”) (NASDAQ: MRCY).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Mercury and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Mercury Systems, Inc. – MRCY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Eagle Pharmaceuticals, Inc. – EGRX

NEW YORK, Jan. 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Eagle and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Eagle Pharmaceuticals, Inc. – EGRX